Dernières nouvelles pour BlackBerry (NYSE:BB) Stock

BlackBerry

BlackBerry, once known for being the world's largest smartphone manufacturer, is now exclusively a software provider with a stated goal of end-to-end secure communications for enterprises. The firm provides endpoint management and other secure communications software to enterprises, specializing in regulated industries like government and financial institutions. BlackBerry also has a sizable embedded software business primarily serving the automotive market, with some exposure to the industrial market.

BlackBerry Ltd

ALIBABA GRP S/ADR 144A 24 by Alibaba Group Holding Limited

JPMorgan BetaBuilders U.S. Aggregate Bond ETF

BB Biotech AG

BigBear.ai Holdings Inc

BigBear.ai, Inc. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share

Banco del Bajio SA

NEW YORK HEALTH CARE INC by New York Health Care, Inc.

New York Health Care Inc

Banco BBVA Argentina SA

JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF

BondBloxx ETF Trust BondBloxx BBB Rated 5-10 Year Corporate Bond ETF

BAKER BOYER BANCORP WALLA by Baker Boyer Bancorp

Baker Boyer Bancorp

BondBloxx ETF Trust BondBloxx BBB Rated 10+ Year Corporate Bond ETF

Huntsman Exploration Inc

HUNTSMAN EXPLORATION INC by Huntsman Exploration Inc.

BondBloxx ETF Trust BondBloxx BBB Rated 1-5 Year Corporate Bond ETF

BLACK BIRD BIOTECH INC by BLACK BIRD BIOTECH INC

Black Bird Biotech Inc

BRIXTON METALS CORP by Brixton Metals Corp.

Brixton Metals Corp

Bed Bath & Beyond Inc

Virtus LifeSci Biotech Clinical Trials ETF

JPMorgan BetaBuilders Canada ETF

JPMorgan BetaBuilders USD Investment Grade Corporate Bond ETF

Blackbird Critical Metals Corp

BLACKBIRD CRTICL METALS by BLACKBIRD CRITICAL METALS CORP.

Concrete Pumping Holdings, Inc. - Common Stock

Concrete Pumping Holdings Inc

Concrete Pumping Holdings Inc Warrants(06/12/2023)

Banco Bradesco Sa American Depositary Shares

Bank Bradesco SA

BEBIDA BEVERAGE CO by Bebida Beverage Co.

Bebida Beverage Co

Barings BDC Inc

Banco Bradesco Sa American Depositary Shares (each representing one Common Share)

BETER BED HLDG NV UNS/ADR by BETER BED HLDG NV

J.P. Morgan Exchange-Traded Fund Trust JPMorgan BetaBuilders Emerging Markets Equity ETF

BIGBEN INTERACTIVE ACT by Bigben Interactive ACT

Bigben Interactive

JPMorgan BetaBuilders Europe ETF

Beasley Broadcast Group, Inc. - Class A Common Stock

Beasley Broadcast Group Inc

VanEck Biotech ETF

JPMorgan BetaBuilders USD High Yield Corporate Bond ETF

J.P. Morgan Exchange-Traded Fund Trust JPMorgan BetaBuilders U.S. Treasury Bond 3-10 Year ETF

VINCO VENTURES INC by Vinco Ventures, Inc.

Vinco Ventures Inc

JPMorgan BetaBuilders International Equity ETF

BridgeBio Pharma Inc

JPMorgan Exchange-Traded Fund Trust Betabuilders US Tips 0-5yr ETF

BONUS BIOGROUP LTD by Bonus Biogroup Ltd.

Bonus BioGroup Ltd

JPMorgan BetaBuilders Japan ETF

BIGG DIGITAL ASSETS INC by BIGG Digital Assets Inc.

BIGG Digital Assets Inc

J.P. Morgan Exchange-Traded Fund Trust JPMorgan BetaBuilders U.S. Treasury Bond 20+ Year ETF

BLOCKCHAIN LOYALTY CORP by Blockchain Loyalty Corp.

Blockchain Loyalty Inc

Bone Biologics Corp

BRITANNIA BULK HLDGS INC by Britannia Bulk Holdings, Inc.

Britannia Bulk Holdings Inc

BABYLON HLDGS LTD A NEW by Babylon Holdings Limited

Babylon Holdings Ltd

Bubblr Inc

Petrolia Energy Corp

EA Series Trust EA Bridgeway Blue Chip ETF

JPMorgan BetaBuilders U.S. Mid Cap Equity ETF

BORDER BANCSHARES ME by Border Bancshares

BBMG Corp

BlackRock Taxable Municipal Bond Trust Common Shares of Beneficial Interest

BlackRock Taxable Municipal Bond Trust

BONVENU BANCORP INC by Bonvenu Bancorp, Inc.

Bonvenu Bancorp Inc

Beta Bionics Inc

BLACK BOX ENTERTAINMENT by Black Box Entertainment Ltd.

Black Box Entertainment Ltd

BEBOP CHANNEL CORP by BeBop Channel Corporation

BeBop Channel Corp

BridgeBio Oncology Therapeutics

Virtus LifeSci Biotech Products ETF

Blackbird PLC

JPMorgan BetaBuilders MSCI U.S. REIT ETF

BLUEBERRIES MEDICAL CO by Blueberries Medical Co.

Blueberries Medical Corp

BrewBilt MFG Inc

Burberry Group PLC

BBS Network

JPMorgan Exchange-Traded Fund Trust BetaBuilders 1-5 Yr US Aggregate Bd ETF

J.P. Morgan Exchange-Traded Fund Trust JPMorgan BetaBuilders U.S. Treasury Bond 1-3 Year ETF

JPMorgan BetaBuilders U.S. Small Cap Equity ETF

BB SEGURIDADE PART SA ADR by BB Seguridade Participacoes SA

BB Seguridade Participacoes SA

Barrett Business Services, Inc. - Common Stock

Barrett Business Services Inc

Bluestone Resources Inc

BTAB ECOMMERCE GROUP INC by Btab Ecommerce Group, Inc.

Btab Ecommerce Group Inc

BBTV Holdings Inc Ordinary Shares (Sub Voting)

Brookfield Business Partners L.P. Limited Partnership Units

Brookfield Business Partners LP

Brookfield Business Corporation Class A Exchangeable Subordinate Voting Shares

Brookfield Business Corp

BIG BUCK BRWRY&STKHSE by Big Buck Brewery & Steakhouse, Inc.

JPMorgan BetaBuilders U.S. Equity ETF

Bebuzee Inc

Banco Bilbao Vizcaya Argentaria S.A. Common Stock

Banco Bilbao Vizcaya Argentaria SA

BANCO BILBAO V/ARGNTNA SA by Banco Bilbao Vizcaya Argentaria, S.A.

Build-A-Bear Workshop Inc

Bath & Body Works Inc

BBX Capital Inc

Best Buy Co Inc

ABRA INFORMATION TECH LTD by ABRA INFORMATION TECHNOLOGIES LTD

BABYTREE GROUP by BABYTREE GROUP

Benzinga examined the prospects for <a href="http://www.benzinga.com/trading-ideas" target="_blank" rel="noreferrer noopener">many investors' favorite stocks</a> over the last week — here's a look at some of our top stories.
Wall Street surged this week as easing geopolitics and a potential pause in U.S.-China tariffs lifted sentiment. The S&amp;P 500 and Nasdaq hit record highs, boosted significantly by Nvidia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), whose stock jumped by about 10% to record its highest valuation — $3.8 trillion — overtaking Microsoft (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) as the world's most valuable company
The tech rally reflected strong earnings from Nvidia's AI-centric chip business and supplier Micron (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), while broader market gains were bolstered by renewed risk appetite in equities.
Next week, investors will track the June jobs report, rhetoric on tariffs — including the July 8 "Liberation Day" deadline — and upcoming July 4 tax‑and‑spending legislative actions that could influence rates and yields.
Benzinga provides daily reports on the stocks most popular with investors. Here are a few of this past week's most bullish and bearish posts that are worth another look.

The Bulls
<a href="https://www.benzinga.com/markets/tech/25/06/46081553/nvidias-jensen-huang-sparks-quantum-stock-frenzy">"Nvidia's Big Moment Is Back—Stock Soared 500% The Last Time This Happened"</a>, by Piero Cingari, reports that Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) is forming a bullish golden cross — a 50-day moving average crossing above the 200‑day — after recovering from earlier tariff-induced weakness, which historically has preceded massive rallies, with gains as high as 800%, fueled by easing U.S.-China trade tensions and strong earnings.
<a href="https://www.benzinga.com/markets/earnings/25/06/46104401/micron-q3-earnings-revenue-eps-beat-estimates-data-center-revenue-guidance-ai-demand">"Micron Q3 earnings: Revenue, EPS beat estimates as data center revenue doubles, strong guidance on rising AI‑driven demand"</a>, by Adam Eckert, reports that Micron Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>) delivered a strong Q3 with $9.3 billion in revenue (beating $8.87 billion estimates) and $1.91 adjusted EPS (versus $1.60 expected); data-center revenue more than doubled, and the company forecast Q4 revenue of $10.7 billion and EPS of $2.50 amid surging AI memory demand.
<a href="https://www.benzinga.com/trading-ideas/movers/25/06/46098312/palantir-stock-hits-all-time-high-whats-going-on">"Palantir stock hits all‑time high: what's going on?"</a>, by Adam Eckert, reports that Palantir Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) shares reached record highs — up roughly 500% over the past year and 93% year-to-date — driven by strong momentum (Benzinga Pro momentum score of 99), surging AI and government contracts including a $795 million U.S. Army deal, and positive Wall Street sentiment such as Loop Capital's raised price target.
For additional bullish calls of the past week, check out the following:
<a href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details">BlackBerry Stock Climbs After Better-Than-Expected Q1 Report: Details</a>
<a href="https://www.benzinga.com/markets/commodities/25/06/46120819/platinum-miners-forecasts-stocks">Platinum's Biggest Rally In 40 Years: These 6 Mining Stocks Could Be Top Gainers</a>
<a href="https://www.benzinga.com/trading-ideas/movers/25/06/46129177/pony-ai-stock-pops-on-report-uber-is-in-talks-with-travis-kalanick-to-invest-in-potential-deal">Pony AI Stock Pops On Report Uber Is In Talks With Travis Kalanick To Invest In Potential Deal</a>

The Bears
<a href="https://www.benzinga.com/trading-ideas/technicals/25/06/46080036/hims-crashes-on-novo-glp-1-fallout-buy-the-dip-or-bail">"HIMS crashes on Novo GLP‑1 fallout: buy‑the‑dip or bail?"</a>, by Surbhi Jain, reports that Hims &amp; Hers Health Inc. (NYSE: HIMS) shares plunged 34% after Novo Nordisk (NYSE: NVO) ended their partnership over claims of unapproved Wegovy compounding, with analysts warning that legal risk and lofty valuation may outweigh oversold technicals.
<a href="https://www.benzinga.com/news/health-care/25/06/46116103/altimmune-stock-sinks-after-mid-stage-data-from-fatty-liver-candidate">"Altimmune stock sinks after mid‑stage data from fatty liver candidate"</a>, by Vandana Singh, reports that Altimmune Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALT#NASDAQ">ALT</a>) shares plunged after its Phase 2b trial showed pemvidutide resolved MASH in over half of treated patients (59.1% at 1.2 mg and 52.1% at 1.8 mg) with significant liver‑fat reduction, but missed the fibrosis endpoint — prompting broad investor concern.
<a href="https://www.benzinga.com/news/space/25/06/46055895/ast-spacemobile-stock-downgraded-rocket-lab-prepares-electron-launch-space-stock-countdown">"AST SpaceMobile stock downgraded, Rocket Lab prepares Electron launch: Space stock countdown"</a>, by Erica Kollmann, reports that AST SpaceMobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) was downgraded by Scotiabank to Sector Perform with a $45.40 target, even as Rocket Lab Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) gears up for another Electron launch — factors highlighting heightened volatility in space stocks.
For more bearish takes, be sure to see these posts:
<a href="https://www.benzinga.com/markets/earnings/25/06/46083155/aerovironment-stock-sinks-despite-better-than-expected-q4-report-heres-why">AeroVironment Stock Sinks Despite Better-Than-Expected Q4 Report: Here's Why</a>
<a href="https://www.benzinga.com/markets/earnings/25/06/46128371/concentrix-stock-slips-after-mixed-q2-results-details">Concentrix Stock Slips After Mixed Q2 Results: Details</a>
<a href="https://www.benzinga.com/trading-ideas/movers/25/06/46118143/unity-software-stock-is-sliding-today-whats-going-on">Unity Software Stock Is Sliding Today: What's Going On?</a>

Keep up with all the latest breaking news and trading ideas by following <a href="https://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener">Benzinga</a><a href="http://twitter.com/Benzinga" target="_blank" rel="noreferrer noopener"> on X</a>.
Image created using artificial intelligence via Midjourney.

Markets

ASTS

AVAV

CNXC

Hims & Hers Health, Inc. Class A Common Stock

HIMS

MSFT

NVDA

PLTR

PONY

RKLB

Benzinga Bulls And Bears: Nvidia, Micron, HIMS — And Markets Soar On Mideast And Tariff Relief

BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) shares experienced a significant surge on Wednesday after the company reported better-than-expected first-quarter financial results and raised its fiscal 2026 sales guidance on Tuesday.
BlackBerry reported <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details" rel="noreferrer noopener">quarterly earnings of</a> two cents per share, which beat the analyst consensus estimate of&nbsp;zero cents. Quarterly revenue of $121.7 million&nbsp;beat the Street estimate of&nbsp;$112.18 million.
QNX revenue increased 8% to $57.5 million, while Secure Communications&#8217; revenue exceeded previously provided guidance at $59.5 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44633991/blackberrys-qnx-secure-comms-growth-weighed-down-by-tariff-uncertainties-government-election-shifts-analyst" rel="noreferrer noopener">BlackBerry&#8217;s QNX, Secure Comms Growth Weighed Down By Tariff Uncertainties, Government Election Shifts: Analyst</a>
BlackBerry affirmed its fiscal 2026 adjusted EPS guidance of 8 cents to 10 cents. The company raised its fiscal 2026 revenue guidance from $504 million-$534 million&nbsp;to $508 million-$538 million versus the $513.51 million&nbsp;estimate.
Following the strong results, Wall Street analysts re-evaluated their positions and raised their price forecasts for BlackBerry.
RBC Capital analyst Paul Treiber maintained a <a target="_blank" href="https://www.benzinga.com/quote/BB/analyst-ratings" rel="noreferrer noopener">Sector Perform rating</a> on BlackBerry while slightly increasing his price forecast from $3.75 to $4.
Treiber&#8217;s assessment highlighted that BlackBerry&#8217;s first-quarter results surpassed both RBC&#8217;s and consensus estimates, primarily due to stronger-than-expected revenue from the Secure Communications and QNX segments.
However, he noted that the company&#8217;s slightly raised fiscal 2026 guidance remains conservative, as it still anticipates an uncertain automotive and broader macro-environment.
Despite experiencing healthy pipeline growth, Treiber emphasized that visibility into auto production remains low, and new deals might face delays.
Canaccord Genuity analyst Kingsley Crane maintained a Hold rating on BlackBerry shares while modestly increasing the price forecast from $4.25 to $4.60.
BlackBerry reported first-quarter results meaningfully ahead of Crane&#8217;s expectations, highlighted by strong IoT or QNX results, which continues to be the standout leader within the business.
The analyst noted that Secure Communications turned in a solid performance amidst a challenging backdrop, driven by ongoing headwinds in the UEM portion of the business.
He said that Unified Endpoint Management (UEM) revenue grew sequentially in the fourth quarter, but challenges in the segment were cited to have affected the decline in ARR.
As Crane looks ahead to the remainder of the calendar year 2025, he sees a distinctly improved outlook for BlackBerry&#8217;s business compared to the previous year.
The analyst noted that strategic initiatives will be incrementally streamlined, and meaningfully positive adjusted EBITDA creates new organic and inorganic investment opportunities.
A ~$865 million QNX backlog offers significant revenue opportunities in the coming years. However, Crane, while acknowledging this significant opportunity, expressed a need for greater clarity on the precise timing and pace at which this backlog will translate into a substantial acceleration, or &#8220;inflection,&#8221; in IoT (Internet of Things) growth.
This visibility challenge is further exacerbated by ongoing uncertainties surrounding auto tariffs. These tariffs can disrupt automotive production volumes, potentially delaying the conversion of QNX backlog into recognized revenue, even though the contracts themselves remain intact.
Crane said management&#8217;s tone has improved considerably in one quarter, but fiscal guidance raised by less than the in-quarter beat ultimately reflects ongoing prudence as the company navigates a dynamic macroeconomic environment.
The analyst noted that less than half of BlackBerry&#8217;s QNX revenue was driven by North America in fiscal 2025, as well as a budding general embedded opportunity (medical, industrial automation, robotics), which represented 18% of QNX revenue in fiscal 2025.
Looking ahead, the general embedded opportunity is poised for substantial expansion, representing a considerable 43% of the overall pipeline for SDV (Software-Defined Vehicle) 8.0.
This strong pipeline suggests that BlackBerry is strategically positioned to make more material sales and marketing investments to accelerate conversions and capitalize on these promising non-automotive end markets.
Price Action: BB stock is trading higher by 15.5% to $5.00 at last check Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/reiteration/25/06/46078928/apple-may-finally-catch-up-in-ai-analyst-sees-big-upside-from-perplexity-deal-smarter-siri-google-search-rivalry" target="_blank" rel="noreferrer noopener">Apple May Finally Catch Up In AI: Analyst Sees Big Upside From Perplexity Deal, Smarter Siri, Google Search Rivalry</a></li>
</ul>
Photo by Michael Vi via Shutterstock

News

Price Target

Reiteration

Analyst Ratings

Movers

Tech

Trading Ideas

This Isn't Your Father's BlackBerry, And Its Comeback Is Gaining Traction

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) posted better-than-expected first-quarter results after <a href="https://www.benzinga.com/quote/BB/earnings">Tuesday&#8217;s closing bell</a>.
BlackBerry reported quarterly earnings of two cents per share, which beat the analyst consensus estimate of zero cents. Quarterly revenue of $121.7 million beat the Street estimate of $112.18 million.
"BlackBerry made a strong start to the new fiscal year, building on the solid foundation we as a company have laid over the past year," said John J. Giamatteo, CEO of BlackBerry. "Both our QNX and Secure Communications divisions continue to execute effectively against their strategies, beating both top line and profitability expectations."
BlackBerry affirmed its fiscal 2026 adjusted EPS guidance of a range of eight cents to 10 cents. The company raised its fiscal 2026 revenue guidance from a range of $504 million to $534 million to a new range of between $508 million and $538 million, versus the $513.51 million estimate.
BlackBerry shares jumped 14.7% to trade at $4.9649 on Wednesday.
These analysts made changes to their price targets on BlackBerry following earnings announcement.
<ul class="wp-block-list">
<li>Baird analyst Luke Junk maintained BlackBerry with a Neutral and raised the price target from $4 to $5.</li>
<li>Canaccord Genuity analyst Kingsley Crane maintained the stock with a Hold and raised the price target from $4.25 to $4.6.</li>
<li>RBC Capital analyst Paul Treiber maintained BlackBerry with a Sector Perform and raised the price target from $3.75 to $4.</li>
</ul>
Considering buying BB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/BB/analyst-ratings"><img loading="lazy" decoding="async" width="1015" height="647" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25132136/image-389.png" alt="" class="wp-image-962018" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25132136/image-389.png 1015w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25132136/image-389-300x191.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/25132136/image-389-768x490.png 768w" sizes="(max-width: 1015px) 100vw, 1015px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june">Top 3 Real Estate Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

Earnings

BlackBerry Analysts Boost Their Forecasts After Upbeat Earnings

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) stock is trading higher Wednesday after the company reported better-than-expected first-quarter <a href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details">financial results</a>.
What To Know: BlackBerry <a href="https://www.benzinga.com//node/46084333">reported first-quarter</a> adjusted earnings per share of 2 cents, beating the consensus estimate for breakeven earnings. In addition, BlackBerry reported sales of $121.7 million, beating the consensus estimate of $112.18 million, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Broken down by segment, the company reported that QNX revenue came in at $57.5 million, up 8% year-over-year, and Secure Communications revenue came in at $59.5 million.
Blackberry ended the quarter with $381.9 million in cash, cash equivalents and short-term and long-term investments, down $28.4 million sequentially. The company said it repurchased 2.57 million shares throughout the quarter.
Q2 Outlook: BlackBerry expects earnings per share of breakeven to one cent, versus the consensus estimate of one cent. Furthermore, the company sees sales from $115 million to $125 million, versus the consensus estimate of $122.35 million.
FY26 Outlook: Blackberry anticipates adjusted earnings per share of eight cents to 10 cents, versus the consensus estimate of 10 cents. Additionally, the company now expects sales from $508 million to $538 million, versus the consensus estimate of $513.51 million. The company previously expected sales of $504 million to $534 million.
Analysts Changes: Following the earnings report, multiple analysts issued price target adjustments.
<ul class="wp-block-list">
<li>Baird analyst Luke Junk maintained a Neutral rating on BlackBerry and raised the price target from&nbsp;$4&nbsp;to&nbsp;$5.</li>
<li>Canaccord Genuity analyst Kingsley Crane maintained a Hold rating on BlackBerry and raised the price target from $4.25 to $4.60.</li>
<li>RBC Capital analyst Paul Treiber maintained a Sector Perform rating on BlackBerry and raised the price target from&nbsp;$3.75&nbsp;to&nbsp;$4.</li>
</ul>
See Also: <a href="https://www.benzinga.com/etfs/sector-etfs/25/06/46098656/nvidia-amazon-tesla-among-tech-stocks-hedge-funds-are-piling-into-heres-how-etfs-like-ivv-spy-voo-are-riding-the-wave">Nvidia, Amazon, Tesla Among Tech Stocks Hedge Funds Are Piling Into — Here&#8217;s How ETFs Like IVV, SPY, VOO Are Riding The Wave</a>
BB Price Action: At the time of writing, Blackberry stock was up 16.2% at $5.02, according to data from <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Image via Shutterstock.

BlackBerry Stock Is Rising Wednesday: What's Going On?

U.S. stocks were mixed, with the Dow Jones index falling around 0.2% on Wednesday.
Shares of AeroVironment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) rose sharply during Wednesday's session after the company reported <a href="https://www.benzinga.com/markets/earnings/25/06/46083155/aerovironment-stock-sinks-despite-better-than-expected-q4-report-heres-why">better-than-expected quarterly financial results</a>.
AeroVironment reported quarterly earnings of $1.61 per share, which beat the $1.42 analyst consensus estimate, according to data from Benzinga Pro. Quarterly revenue came in at&nbsp; $275.05 million, beating the Street estimate of $242.69 million.
AeroVironment shares jumped 24% to $239.57 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) shares jumped 34.1% to $32.81. Nektar Therapeutics recently announced data from the 16-week induction period of the ongoing Phase 2b REZOLVE-AD study of investigational rezpegaldesleukin.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) gained 31.6% to $5.70 after the company achieved a key 2025 milestone by successfully integrating its advanced Cobra separator process into baseline cell production.</li>
<li>Anbio Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NNNN#NASDAQ">NNNN</a>) jumped 27.1% to $30.61.</li>
<li>Bumble Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) jumped 19.9% to $6.24. 19.7% to $6.24 after the company announced it is reducing the size of its team.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) rose 19.1% to $31.77.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) gained 18.1% to $9.60.</li>
<li>BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) rose 16.3% to $5.03 after the company reported better-than-expected first-quarter financial results and raised its FY26 sales guidance.</li>
<li>Yatsen Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YSG#NYSE">YSG</a>) gained 15.1% to $11.12.</li>
<li>Chime Financial, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHYM#NASDAQ">CHYM</a>) rose 13% to $32.77.</li>
<li>TMC the metals company Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMC#NASDAQ">TMC</a>) gained 9.8% to $7.26 after Wedbush upgraded the stock from Neutral to Outperform and raised its price target from $6 to $11.</li>
<li>Symbotic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYM#NASDAQ">SYM</a>) rose 9.5% to $35.25.</li>
<li>Light &amp; Wonder, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNW#NASDAQ">LNW</a>) gained 9.1% to $93.65.</li>
<li>Korea Electric Power Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEP#NYSE">KEP</a>) rose 8.6% to $13.70.</li>
<li>TTM Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTMI#NASDAQ">TTMI</a>) gained 6% to $40.12.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) jumped 5.5% to $45.18.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june">Top 3 Real Estate Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

BMBL

CHYM

LIMN

NKTR

NNNN

SMCI

TIGR

TTMI

AeroVironment Posts Better-Than-Expected Earnings, Joins QuantumScape, Bumble, BlackBerry And Other Big Stocks Moving Higher On Wednesday

RBC Capital analyst Paul Treiber maintains BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) with a Sector Perform and raises the price target from $3.75 to $4.

RBC Capital Maintains Sector Perform on BlackBerry, Raises Price Target to $4

Canaccord Genuity analyst Kingsley Crane maintains BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) with a Hold and raises the price target from $4.25 to $4.6.

Canaccord Genuity Maintains Hold on BlackBerry, Raises Price Target to $4.6

Baird analyst Luke Junk maintains BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) with a Neutral and raises the price target from $4 to $5.

Baird Maintains Neutral on BlackBerry, Raises Price Target to $5

WIIM

BlackBerry shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY26 sales guidance.

Shares of BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) rose sharply in today's pre-market trading following <a href="https://www.benzinga.com/markets/earnings/25/06/46084802/blackberry-stock-climbs-after-better-than-expected-q1-report-details">first-quarter results</a>.
BlackBerry reported quarterly earnings of two cents per share, which beat the analyst consensus estimate of zero cents. Quarterly revenue of $121.7 million beat the Street estimate of $112.18 million.
The company raised its fiscal 2026 revenue guidance from a range of $504 million to $534 million to a new range of between $508 million and $538 million, versus the $513.51 million estimate.
BlackBerry shares jumped 14.7% to $4.96 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>NaaS Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAAS#NASDAQ">NAAS</a>) surged 40.6% to $1.08 in pre-market trading after gaining 4% on Tuesday.</li>
<li>QuantumScape Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QS#NYSE">QS</a>) gained 31.1% to $5.66 in pre-market trading after the company achieved a key 2025 milestone by successfully integrating its advanced Cobra separator process into baseline cell production.</li>
<li>Beeline Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLNE#NASDAQ">BLNE</a>) gained 27.5% to $1.81 in pre-market trading after jumping 29% on Tuesday.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) rose 22.5% to $32.70 in pre-market trading after jumping over 33% on Tuesday.</li>
<li>Genius Group Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GNS#NYSE">GNS</a>) jumped 20.8% to $0.8152 in pre-market trading after gaining more than 30% on Tuesday.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) climbed 14.6% to $26.30 in pre-market trading.</li>
<li>Impact BioMedical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBO#NYSE">IBO</a>) gained 13.2% to $0.9566 in pre-market trading after dipping 48% on Tuesday. Impact BioMedical recently announced a limited merger and share exchange agreement with Dr Ashleys.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) rose 14.2% to $9.30 in pre-market trading.</li>
<li>Worthington Enterprises, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) gained 10.5% to $66.44 in pre-market trading as the company reported better-than-expected fourth-quarter financial results.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>XTI Aerospace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTIA#NASDAQ">XTIA</a>) shares tumbled 31.2% to $1.92 in pre-market trading after the company announced the pricing of $16 million public offering.</li>
<li>Torrid Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAAS#NASDAQ">MAAS</a>) shares fell 29.2% to $3.61 in pre-market trading.</li>
<li>FAST TRACK GROUP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRK#NASDAQ">FTRK</a>) dipped 19.2% to $2.01 in pre-market trading after dipping 60% on Tuesday.</li>
<li>OneMedNet Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONMD#NASDAQ">ONMD</a>) declined 14.3% to $0.5850 in pre-market trading. OneMedNet shares jumped over 100% on Tuesday after the company entered into private placement agreements with accredited investors raising approximately $3.7 million in gross proceeds.</li>
<li>InspireMD, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSPR#NASDAQ">NSPR</a>) dipped 12.1% to $2.19 in pre-market trading after the company received FDA premarket application approval for CGuard Prime Carotid Stent System.</li>
<li>Greenlane Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) fell 11.2% to $0.0079 in pre-market trading. Greenlane announced a 1-for-750 reverse stock split, effective on June 26.</li>
<li>XTL Biopharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTLB#NASDAQ">XTLB</a>) declined 11.1% to $1.16 in pre-market trading after gaining 28% on Tuesday.</li>
<li>Allot Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLT#NASDAQ">ALLT</a>) fell 9% to $8.75 in pre-market trading after the company announced the pricing of underwritten public offering of ordinary shares.</li>
<li>Cidara Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTX#NASDAQ">CDTX</a>) fell 6.6% to $43.75 in pre-market trading after the company announced the pricing of upsized public offering of common stock.</li>
<li>FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) fell 5.4% to $216.85 in pre-market trading following soft first-quarter guidance.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46072226/top-3-real-estate-stocks-you-may-want-to-dump-in-june">Top 3 Real Estate Stocks You May Want To Dump In June</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

ALLT

BLNE

CDTX

FTRK

GNLN

Highest Performances Holdings Inc. - American Depository Shares

MAAS

NAAS

NSPR

ONMD

XTIA

XTLB

Why BlackBerry Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) released its first-quarter results after Tuesday's closing bell. Here's a look at the details <a href="https://www.benzinga.com/pressreleases/25/06/ac46084333/blackberry-reports-first-quarter-fiscal-year-2026-results">in the report. </a>
The Details: BlackBerry reported quarterly earnings of two cents per share, which beat the analyst consensus estimate of zero cents. Quarterly revenue of $121.7 million beat the Street estimate of $112.18 million.
Read Next: <a href="https://www.benzinga.com/news/space/25/06/46055895/ast-spacemobile-stock-downgraded-rocket-lab-prepares-electron-launch-space-stock-countdown?utm_source=articleShare">AST SpaceMobile Stock Downgraded, Rocket Lab Prepares Electron Launch: Space Stock Countdown</a>
For the first quarter, BlackBerry reported: 
<ul class="wp-block-list">
<li>Total company non-GAAP gross margin was 75%.</li>
<li>QNX revenue delivered 8% year-over-year growth to $57.5 million; QNX adjusted gross margin was 81%. </li>
<li>Secure Communications revenue exceeded previously-provided guidance at $59.5 million; Secure Communications adjusted gross margin increased by 6 percentage points sequentially and 4 percentage points year-over-year to 70%. </li>
<li>Licensing revenue was $4.7 million, and adjusted EBITDA was $3.8 million. </li>
</ul>
&#8220;BlackBerry made a strong start to the new fiscal year, building on the solid foundation we as a company have laid over the past year,&#8221; said John J. Giamatteo, CEO of BlackBerry. 
&#8220;Both our QNX and Secure Communications divisions continue to execute effectively against their strategies, beating both top line and profitability expectations.&#8221;
Outlook: BlackBerry affirmed its fiscal 2026 adjusted EPS guidance of a range of eight cents to 10 cents. The company raised its fiscal 2026 revenue guidance from a range of $504 million to $534 million to a new range of between $508 million and $538 million, versus the $513.51 million estimate.
BB Price Action: According to data from<a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw"> Benzinga Pro</a>, BlackBerry stock was up 4.16% at $4.51 in Tuesday's extended trading. 
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/46056665/unitedhealth-cvs-among-major-insurers-to-fast-track-prior-authorizations-will-it-cut-profits-even-more?utm_source=articleShare">UnitedHealth, CVS Among Major Insurers To Fast-Track Prior Authorizations: Will It Cut Profits Even More?</a></li>
</ul>
Image: Shutterstock&nbsp;

After-Hours Center

BlackBerry Stock Climbs After Better-Than-Expected Q1 Report: Details

BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) affirms FY2026 Adj EPS guidance from $0.08-$0.10 to $0.08-$0.10 vs $0.10 analyst estimate. Raises FY2026 sales outlook from $504.000 million-$534.000 million to $508.000 million-$538.000 million vs $513.510 million estimate.

Guidance

BlackBerry Affirms FY2026 Adj EPS Guidance of $0.08-$0.10 vs $0.10 Est; Raises FY2026 Sales Guidance from $504.000M-$534.000M to $508.000M-$538.000M vs $513.510M Est

BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) Q2 expected to be Breakeven - $0.01 vs $0.01 Est. sees Q2 sales of $115.000 million-$125.000 million vs $122.353 million analyst estimate.

BlackBerry Q2  expected to be $0 to $0.01 vs $0.01 Est; Sees Q2 Sales $115.000M-$125.000M vs $122.353M Est

BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.00 by 566.67 percent. This is a 166.67 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $121.700 million which beat the analyst consensus estimate of $112.185 million by 8.48 percent. This is a 15.49 percent decrease over sales of $144.000 million the same period last year.

Earnings Beats

BlackBerry Q1 Adj. EPS $0.02 Beats $0.00 Estimate, Sales $121.700M Beat $112.185M Estimate

U.S. futures were trading higher on Tuesday after a positive day of trading on Monday. Futures of major benchmark indices were trading higher.
President Donald Trump announced a &#8220;<a href="https://www.benzinga.com/news/25/06/46066239/dow-futures-jump-over-200-points-as-trump-announces-ceasefire-but-iran-says-no-agreement-crude-plunges">ceasefire</a>&#8221; in a Truth Social post, saying that "THE 12 DAY WAR" will be considered "ended." 
Despite this, the Foreign Minister of Iran, Syed Abbas Araghchi, refuted claims of a ceasefire, saying that there was "no agreement" for cessation of military operations, in a post on X.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">As Iran has repeatedly made clear: Israel launched war on Iran, not the other way around. As of now, there is NO &quot;agreement&quot; on any ceasefire or cessation of military operations. However, provided that the Israeli regime stops its illegal aggression against the Iranian people no…
&mdash; Seyed Abbas Araghchi (@araghchi) <a href="https://twitter.com/araghchi/status/1937311435882922420?ref_src=twsrc%5Etfw">June 24, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The 10-year Treasury bond yielded 4.35% and the two-year bond was at 3.84%. The CME Group's FedWatch <a href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>&#8216;s projections show markets pricing a 77.3% likelihood of the Federal Reserve keeping the current interest rates unchanged in its July meeting. 
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Futures</td>
<td>Change (+/-)</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.69%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.79%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>1.02%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.18%</td>
</tr>
</tbody>
</table>
</figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Tuesday. The SPY was up 0.83% at $605.11, while the QQQ advanced 1.11% to $537.56, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Cues From Last Session:
On Monday, U.S. stocks saw gains across most S&amp;P 500 sectors, with consumer discretionary, consumer staples, and real estate stocks leading the charge, though energy stocks diverged, ending the session in the red.
Economically, the S&amp;P Global US services PMI dropped to 53.1 in June from 53.7 the prior month, falling short of market expectations of 52.9. Meanwhile, the S&amp;P Global US manufacturing PMI held steady at 52 in June, matching the previous month's figure.
Shares of FactSet Research Systems Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) rose approximately 3.5% on Monday after the company released its third-quarter results.
The Dow Jones index ended 375 points or 0.89% higher at 42,581.78, whereas the S&amp;P 500 index rose 0.96% to 6,025.17. Nasdaq Composite advanced 0.94% to 19,630.98, and the small-cap gauge, Russell 2000, gained 1.11% to end at 2,132.68.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Index</td>
<td>Performance (+/-)</td>
<td>Value</td>
</tr>
<tr>
<td>Nasdaq Composite</td>
<td>0.94%</td>
<td>19,630.98</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>0.96%</td>
<td>6,025.17</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>0.89%</td>
<td>42,581.78</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>1.11%</td>
<td>2,132.68</td>
</tr>
</tbody>
</table>
</figure>
Insights From Analysts:
Senior economist Jeremy Siegel expressed his opinions on the ongoing tensions as Trump announced a ceasefire.
&#8220;Geopolitics is a wildcard, but the U.S. is far less exposed than it was in the 1970s. Even a brief closure of the Strait of Hormuz would not derail domestic growth—shale capacity and strategic reserves mute the blow,&#8221; he said.
&#8220;I maintain that investors should stay overweight equities versus bonds,&#8221; he added, sayin that &#8220;don't just chase the AI enablers at high multiples to earnings; real margin expansion could very well accrue to users of AI—banks, industrial, consumer-staples, mid-cap firms that are learning where they can cut costs, increase output and improve margins.&#8221;
In its most recent note, BlackRock spotlighted the <a href="https://www.benzinga.com/markets/equities/25/06/46068345/blackrock-bets-big-on-defense-companies-amid-escalating-geopolitical-tensions-palantir-lockheed-">defense sector as a top investment prospect</a>, fueled by escalating geopolitical fragmentation and a worldwide focus on national security.
As per BlackRock, the U.S. distinguishes itself through its extensive defense spending, which, according to SIPRI data, "spends more than double on defense than Europe."
Moreover, the U.S. hosts the world's most advanced defense and defense technology companies, acting as a vital provider of critical systems like air and missile defense for numerous countries.
Within the defense sector, BlackRock identifies substantial opportunities in defense tech. This expansive field includes not just artificial intelligence (AI) and software firms but also crucial IT services and hardware, such as semiconductors, that drive cutting-edge defense capabilities.
BlackRock observes that "growing geopolitical fragmentation and strategic competition in AI are reinforcing the global focus on national security and resilience – creating opportunities in defense." This highlights a targeted investment strategy in defense, where technological leadership and strong national security frameworks are increasingly critical.
See Also: <a href="https://www.benzinga.com/money/how-to-trade-futures">How to Trade Futures</a> 
Upcoming Economic Data
Here&#8217;s what investors will keep an eye on Tuesday:
<ul class="wp-block-list">
<li>April&#8217;s S&amp;P Case-Shiller home price index for 20 cities will be released by 9:00 a.m., and Cleveland Fed President Beth Hammack will speak at 9:15 a.m. ET.</li>
<li>June consumer confidence data will be out by 10:00 a.m., and the Fed Chairman Jerome Powell will testify to the House Financial Services Committee at 10:00 a.m. ET.</li>
</ul>
Stocks In Focus:
<ul class="wp-block-list">
<li>TD Synnex Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) was up 0.58% in premarket on Tuesday as analysts expect it to report quarterly earnings of $2.72 per share on revenue of $14.32 billion, before the opening bell.</li>
<li>Carnival Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCL#NYSE">CCL</a>) rose 2.04% as analysts expect it to report quarterly earnings of 24 cents per share on revenue of $6.21 billion, before the opening bell.</li>
<li>Worthington Enterprises Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) advanced 3.55% as analysts expect it to report quarterly earnings of 84 cents per share on revenue of $301.44 million, before the opening bell.</li>
<li>FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) was 0.47% higher as analysts expect it to report quarterly earnings of $5.87 per share on revenue of $21.84 billion after the closing bell.</li>
<li>KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) was down 0.43% as it revised full-year 2025 housing revenue to be in the range of $6.3 billion to $6.5 billion, down from prior guidance of $6.6 billion to $7 billion.</li>
<li>Chewy Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>) dropped 1.31% as it commenced an underwritten public offering of $1 billion of its Class A common stock by a selling stockholder. It plans to concurrently repurchase $100 million of its common stock from the selling stockholder.</li>
<li>BlackBerry Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) jumped 1.62% as analysts expect it to report quarterly earnings of $0 per share on revenue of $112.19 million after the closing bell.</li>
<li>Ibio Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#NASDAQ">IBIO</a>) surged 44.58% after it announced a conference call scheduled for June 24 to discuss its obesity and cardiometabolic disease pipeline.</li>
<li>Nektar Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKTR#NASDAQ">NKTR</a>) zoomed 31.66% ahead of its investor call, where it plans to present top-line data from the 16-week induction period of its Phase 2b REZOLVE-AD clinical trial.</li>
</ul>
Commodities, Gold, And Global Equity Markets:
Crude oil futures were trading lower in the early New York session by 3.40% to hover around $66.18 per barrel.
Gold Spot US Dollar fell 1.29% to hover around $3,325.68 per ounce. Its last record high stood at $3,500.33 per ounce. The U.S. Dollar Index spot was lower by 0.30% at the 98.1240 level.
Asian markets ended higher on Tuesday as Australia's ASX 200, Japan's Nikkei 225, China&#8217;s CSI 300, South Korea's Kospi, Hong Kong's Hang Seng, and India's S&amp;P BSE Sensex indices advanced. European markets were also higher in early trade.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46068345/blackrock-bets-big-on-defense-companies-amid-escalating-geopolitical-tensions-palantir-lockheed-">BlackRock Bets Big On Defense Companies Amid Escalating Geopolitical Tensions: Palantir, Lockheed Martin, Northrop Grumman Among Stocks In Focus</a></li>
</ul>
Photo courtesy: Shutterstock

Equities

CHWY

IBIO

US Stocks Likely To Open Higher After Trump Announces Iran-Israel Ceasefire: FedEx, TD Synnex In Focus Ahead Of Earnings

<h3>Companies Reporting Before The Bell</h3>
• TH International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/THCH#NASDAQ">THCH</a>) is projected to report earnings for its first quarter. 
• TD Synnex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNX#NYSE">SNX</a>) is expected to report quarterly earnings at $3.03 per share on revenue of $14.76 billion. 
<h3>Companies Reporting After The Bell</h3>
• Anterix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATEX#NASDAQ">ATEX</a>) is expected to report earnings for its fourth quarter. 
• AeroVironment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>) is likely to report quarterly earnings at $1.41 per share on revenue of $242.69 million. 
• Worthington Enterprises (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WOR#NYSE">WOR</a>) is projected to report quarterly earnings at $0.84 per share on revenue of $301.44 million. 
• FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) is expected to report quarterly earnings at $5.89 per share on revenue of $21.82 billion. 
• BlackBerry (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) is projected to report quarterly earnings at $0.00 per share on revenue of $112.18 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ATEX

THCH

Earnings Scheduled For June 24, 2025

BlackBerry Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BB#NYSE">BB</a>) will release earnings results for the first quarter, after the <a href="https://www.benzinga.com/quote/BB/earnings">closing bell on Tuesday, June 24</a>.
Analysts expect the Waterloo, Canada-based company to report quarterly earnings at $0 per share, up from $2.73 per share in the year-ago period. BlackBerry projects to report quarterly revenue of $112.19 million, compared to $144 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Monday, QNX, a subsidiary of BlackBerry, and Vector Informatik signed a Memorandum of Understanding (MoU) to jointly create a new software platform designed to support the development of software-defined vehicles (SDVs).
BlackBerry shares gained 2.1% to close at $4.32 on Monday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/bb/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>CIBC analyst Todd Coupland maintained an Outperformer rating and cut the price target from $7 to $6 on April 3, 2025. This analyst has an accuracy rate of 69%.</li>
<li>RBC Capital analyst Paul Treiber maintained a Sector Perform rating and lowered the price target from $4 to $3.75 on April 3, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Canaccord Genuity analyst Michael Walkley maintained a Hold rating and cut the price target from $4.75 to $4.25 on April 3, 2025. This analyst has an accuracy rate of 75%.</li>
<li>TD Cowen analyst Daniel Chan upgraded the stock from Hold to Buy and raised the price target from $3.25 to $4 on Dec. 20, 2024. This analyst has an accuracy rate of 80%.</li>
</ul>
Considering buying BB stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/BB/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="547" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24025023/image-345-1024x547.png" alt="" class="wp-image-959147" style="width:597px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24025023/image-345-1024x547.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24025023/image-345-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24025023/image-345-768x410.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/24025023/image-345.png 1162w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46050117/wall-streets-most-accurate-analysts-give-their-take-on-3-tech-stocks-delivering-high-dividend-yields-7">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Tech Stocks Delivering High-Dividend Yields</a> </li>
</ul>
Photo via Shutterstock

Comments

BlackBerry

Actualités

Dernières nouvelles pour BlackBerry (NYSE:BB) Stock

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL